$8.32
-0.36 (-4.15%)
Open$8.57
Previous Close$8.68
Day High$8.79
Day Low$8.30
52W High$16.52
52W Low$6.47
Volume—
Avg Volume62.5K
Market Cap39.94M
P/E Ratio—
EPS$-6.57
SectorBiotechnology
Analyst Ratings
Strong Buy
5 analysts
Price Target
+500.2% upside
Current
$8.32
$8.32
Target
$49.94
$49.94
$27.43
$49.94 avg
$65.11
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.43M | 12.59M | 12.91M |
| Net Income | -77,429,863 | -1,338,243 | -1,683,285 |
| Profit Margin | -918.1% | -10.6% | -13.0% |
| EBITDA | -75,111,098 | -1,969,871 | -1,762,148 |
| Free Cash Flow | — | -1,414,748 | -1,276,245 |
| Rev Growth | — | -1.9% | -7.4% |
| Debt/Equity | — | 1.05 | 0.93 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |